Lobby fears norms violation in Cipla's biosimilar drug

A lobby group of biotech drug companies in India has raised concerns about the approval of Cipla's first biosimilar drug Etanercept.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news